Differential diagnoses: How to determine cause of visual field loss

Article

Management decisions for a patient who presents with a visual field defect should never be made before considering a host of other etiologies that can masquerade as glaucoma by the type of visual field loss.

New York-Management decisions for a patient who presents with a visual field defect (VFD) should never be made before considering a host of other etiologies that can masquerade as glaucoma by the type of visual field loss (VFL), said Sherry J. Bass, OD, FAAO, at International Vision Expo East.

Consider big picture

VFL associated with glaucoma presents initially as paracentral defects with progression to nasal step defects, arcuate and Bjerrum defects, altitudinal defects, and ultimately, if the disease is not controlled, peripheral field constriction. For each of these types of defects, there are different etiologies to consider as an alternative diagnosis.

Non-glaucomatous etiologies of paracentral field loss include hereditary macular disease, such as Stargardt macular degeneration and cone dystrophy, and optic pits. Superior paracentral VFLs can be found in patients with a hereditary macular disease as a result of their typical use of superior eccentric fixation to achieve better vision.

In patients with an optic pit, usually located at the inferior temporal border of the optic nerve head, paracentral field loss is secondary to loss of the retinal nerve fiber layer between the macula and optic nerve that can exist in this condition, Dr. Bass explained.

Nasal field defects are also a sign of early glaucoma but can alternatively be caused by optic disc drusen. Diagnosis of optic disc drusen may be challenged by the fact that the lesions may be buried in younger patients.

"The finding of an optic nerve head with blurry disc borders and no cupping in a patient with a nasal field defect should suggest the diagnosis of optic nerve drusen," Dr. Bass said.

"Further evaluation should include B-scan ultrasonography," she continued. "However, this imaging is only effective for identifying drusen that are calcified, which includes about 50% of disc drusen."

Recent Videos
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
Bonnie An Henderson in an interview for the EnVision Summit
From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
© 2025 MJH Life Sciences

All rights reserved.